To enhance the impact of diagnostics, specifically in both limiting antibiotic resistance and providing more focused therapies. Early and targeted therapeutic strategies will give patients a better quality of life.

To retain the network’s jointly generated expertise. Follow-on projects should enable the creation of new and secure jobs for network partners.